In addition, Timp1 (tissue inhibitor of metalloproteinase 1), was identified as a NF-κB target gene that contributes to mouse lung tumor growth [34], and it is highly expressed, and correlates with NF-κB activation in advanced lung-cancer patients with poor prognosis [106,107]. The gene discussed is NFKB1; the disease is lung cancer.